Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of Oral Octreolin™ in Patients With Acromegaly Who Are Currently Receiving Parenteral Somatostatin Analogs
Conditions
Interventions
Octreotide capsules
Locations
36
United States
Cedars-Sinai Medical Center
Los Angeles, California, United States
Campus Charité Mitte
Berlin, Germany
ENDOC Center for Endocrine Tumors
Hamburg, Germany
Medizinische Klinik Innenstadt
Munich, Germany
Max Planck Institute of Psychiatry
Munich, Germany
Praxis for Endocrimology and Diabetology in Oldenburg
Oldenburg, Germany
Start Date
March 1, 2012
Primary Completion Date
May 1, 2014
Completion Date
May 1, 2014
Last Updated
August 17, 2017
NCT00001595
NCT04837040
NCT04125836
NCT06253897
NCT02611336
NCT05184231
Lead Sponsor
Chiasma, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions